Effectiveness of mid-regional pro-adrenomedullin (MR-proADM) as prognostic marker in COVID-19 critically ill patients: An observational prospective study.
<h4>Objective</h4>To test the effectiveness of mid-regional pro-adrenomedullin (MR-proADM) in comparison to C-reactive protein (CRP), procalcitonin (PCT), D-dimer, lactate dehydrogenase (LDH) in predicting mortality in COVID-19-ICU-patients.<h4>Methods</h4>All consecutive COV...
Main Authors: | Giorgia Montrucchio, Gabriele Sales, Francesca Rumbolo, Filippo Palmesino, Vito Fanelli, Rosario Urbino, Claudia Filippini, Giulio Mengozzi, Luca Brazzi |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0246771 |
Similar Items
-
The association of midregional pro-adrenomedullin (MR-proADM) at ICU admission and fluid overload in patients post elective cardiac surgery
by: Carmen A. Pfortmueller, et al.
Published: (2024-09-01) -
Mr-proADM and MR-proANP levels in patients with acute pulmonary embolism
by: Öner Önsel, et al.
Published: (2020-01-01) -
MR-proADM as Prognostic Factor of Outcome in COVID-19 Patients
by: Paolo Cameli, et al.
Published: (2023-06-01) -
Effectiveness of mid-regional pro-adrenomedullin, compared to other biomarkers (including lymphocyte subpopulations and immunoglobulins), as a prognostic biomarker in COVID-19 critically ill patients: New evidence from a 15-month observational prospective study
by: Giorgia Montrucchio, et al.
Published: (2023-03-01) -
The kinetic profiles of copeptin and mid regional proadrenomedullin (MR-proADM) in pediatric lower respiratory tract infections
by: Philipp Baumann, et al.
Published: (2022-01-01)